Ketamine is a dissociative anesthetic used in medical care. It can relieve pain and produce a state in which a person feels disconnected from their body or surroundings. Outside supervised care, its effects, composition and risks can be difficult to predict. Medical usefulness does not make nonmedical use safe.
This guide explains ketamine’s medical uses, short- and longer-term effects, interactions, dependence, withdrawal and when to seek help. Severe breathing difficulty, unconsciousness, seizures, chest pain or rapidly worsening confusion require emergency assistance. Painful or bloody urination after ketamine use also needs medical assessment.
What is ketamine and how does it work?
Ketamine acts mainly by blocking N-methyl-D-aspartate (NMDA) receptors, which are involved in signaling through the neurotransmitter glutamate. Its effects include pain relief, sedation and dissociation. Altered perception can include changes in sensations, time, surroundings or the sense of being in one’s body.
The response depends on the product, amount, route, repeated use, other substances and individual health. Street names such as “K,” “Special K” or “Keta,” and a powder’s appearance, cannot confirm its contents or purity. Ketamine and other dissociative substances are not interchangeable.
Medical uses and therapeutic research
Anesthesia and pain care
Clinicians use ketamine to induce or support anesthesia for selected procedures. Specialists may also use it in particular pain-care settings. The appropriate formulation, indication, monitoring and treatment plan depend on the person and local prescribing rules. These uses require clinical assessment rather than a self-selected dose or schedule.
Ketamine does not guarantee a protected airway. Vomiting, aspiration, excessive sedation and breathing problems can occur, especially with other sedating substances. Heart rate and blood pressure can also change. Medical teams assess risks, monitor the patient and are equipped to manage complications.
Ketamine and esketamine for depression
Ketamine and esketamine are related but distinct medicines and formulations. Esketamine nasal spray has specific approved uses for certain adults with depression under supervised care. The indications, combinations with other treatment and monitoring requirements must follow the applicable product label; approval of the spray does not automatically apply to ketamine injections, compounded products or home use.
Specialists may offer ketamine for some depressive conditions outside its licensed indication, depending on local rules and an individual assessment. Some people experience a rapid reduction in depressive symptoms, but not everyone responds, and the benefit may not last. There is no universal success rate or guaranteed permanent remission.
Improvement in depressive symptoms must not be presented as proof that suicide has been prevented. The FDA’s esketamine label states that effectiveness in preventing suicide or reducing suicidal thoughts or behavior has not been demonstrated. Urgent assessment or hospital care may still be necessary even after an initial improvement.
Other psychiatric conditions and compounded products
Ketamine has been studied for conditions including post-traumatic stress disorder, obsessive-compulsive disorder and substance-use disorders. Promising or conflicting findings do not establish that it is an approved or effective treatment for everyone. A clinician should explain the evidence, alternatives, uncertainties and follow-up required for any proposed use.
Compounded ketamine is different from an approved esketamine product. Compounded products do not undergo the same premarket approval assessment of safety, effectiveness and quality. FDA safety alerts identify concerns with unsupervised psychiatric use, including sedation, dissociation, increased blood pressure, breathing problems, misuse and urinary symptoms.
Short-term effects and side effects
Dissociation may feel dreamlike or detached, but can also be frightening. A person may experience euphoria, altered sensations, hallucinations, distorted time, confusion or panic. Reduced pain perception and impaired judgment can make injuries harder to notice and accidents more likely.
- Nausea, vomiting, dizziness or unsteadiness.
- Drowsiness, confusion and impaired coordination.
- Blurred or double vision and altered perception.
- Anxiety, distress, hallucinations or a disturbing sense of detachment.
- Increased heart rate or blood pressure; other cardiovascular changes can also occur.
- Difficulty communicating clearly or judging the surrounding situation.
Effects that occur in a monitored medical setting can be assessed and managed by clinicians. An unknown illicit product, an unsafe environment or combining substances creates additional uncertainty. A pleasant experience on one occasion does not predict the next response.
Severe intoxication and emergencies
Marked sedation, inability to wake, slow or abnormal breathing, seizures, chest pain, collapse, severe agitation or rapidly worsening confusion require emergency help. An unusual response may involve ketamine, another substance or a separate medical problem; symptoms alone do not establish the product taken.
Call emergency services and explain what is known about the exposure. Stay with the person when it is safe. If they are unconscious but breathing normally, place them in the recovery position; if they are not breathing normally, follow emergency-dispatch instructions for CPR. Do not give food or drink, induce vomiting or attempt a home remedy to reverse intoxication.
Ketamine with alcohol, medicines and other drugs
Alcohol, opioids, benzodiazepines and other central nervous system depressants can increase sedation and the risk of respiratory depression, coma and death when combined with ketamine. Stimulants can add cardiovascular stress and do not reliably counteract sedation or make the combination safe.
Before prescribed treatment, tell the clinical team about all medicines, supplements and substances used, including alcohol. Do not stop a prescribed medicine or alter a ketamine treatment plan independently to manage an interaction. Seek advice from the prescriber or pharmacist.
Longer-term risks: bladder, kidneys, liver and cognition
Ketamine-related urinary tract damage
Repeated ketamine exposure can damage the bladder and other parts of the urinary tract. Symptoms can include urinary urgency, passing urine very often, pain when urinating, pelvic pain, leakage or blood in the urine. Severe disease can affect bladder capacity, obstruct urinary drainage and damage the kidneys. These problems are not restricted to a single pattern or guaranteed threshold of use.
Seek medical assessment promptly for urinary symptoms and tell the clinician about ketamine exposure. Do not keep using ketamine to mask bladder pain or assume that repeated symptoms are always a simple infection. Earlier recognition and stopping harmful exposure with professional support are important; advanced damage may persist and require specialist treatment.
Liver and other physical complications
Recurrent exposure has also been associated with liver and bile-duct injury. Persistent abdominal pain, jaundice or significant illness after use warrants assessment. A clinician may arrange investigations based on symptoms and treatment history. Injecting and sharing equipment can add infection risks, including blood-borne viruses.
Mental health and cognitive effects
Repeated nonmedical use has been associated with difficulties in memory, attention, mood and functioning. Research varies in exposure patterns, other substance use and study design, so brain-imaging findings do not diagnose permanent damage in an individual. Continuing anxiety, depression, dissociation, confusion or memory difficulties deserve professional evaluation.
Can ketamine cause dependence?
Yes. Some people develop strong cravings, use more often or find it difficult to stop despite harm. A substance-use disorder is assessed through impaired control, continued use despite consequences and effects on daily life. It cannot be diagnosed from one exposure alone.
Tolerance and physical dependence have been reported with prolonged ketamine use. Some effects can become less noticeable, but taking more increases risk rather than ensuring safety. Tolerance or physical dependence is not, by itself, the same as addiction. Physical dependence also does not mean that everyone will experience the same withdrawal symptoms.
What can happen when someone stops?
After frequent or prolonged use, reducing or stopping can be followed by craving, fatigue, anxiety, mood changes, altered appetite or disturbed sleep. The available evidence does not define a universal symptom list or fixed timeline for everyone. Double vision, poor coordination, a racing heart or rapid breathing should not automatically be dismissed as harmless withdrawal.
Assessment should consider ongoing intoxication, urinary or other complications, mental health, prescribed medicines and other substance use. Alcohol or benzodiazepine dependence can create additional withdrawal risks requiring medical care. Suicidal thoughts, psychosis, severe physical symptoms or inability to remain safe require urgent assistance rather than unsupported withdrawal at home.
How long do effects and detection last?
Onset, duration and recovery vary with the formulation, route, amount, repeated exposure and other substances. The strongest subjective effects may wear off before judgment and coordination have fully recovered. A half-life is not a countdown to safe driving, drinking alcohol or complete elimination.
There is no single reliable detection window for every urine, blood, saliva or hair test. Tests may measure ketamine or metabolites using different methods and cutoffs. Specimen type, exposure pattern and time since use affect results. A positive result does not by itself prove current impairment, and a routine screening test may not include ketamine.
Getting support for problematic use
A primary-care clinician, addiction service or mental-health team can assess both physical complications and patterns of use. Explain urinary symptoms, mood, sleep, other substances and any prescribed treatment. Care should address immediate safety, medical problems and the person’s goals without judgment.
Support may include psychological therapies, strategies for craving and triggers, peer or family support and treatment of coexisting conditions. The appropriate level of care depends on medical or psychiatric risk, other substances, available support and housing. Residential treatment or a universal “detox” program is not necessary for every person.
Recovery may take time and plans may need adjustment. Sleep, regular meals, supportive relationships and meaningful activities can help alongside professional care. No clinic, medicine or therapy can guarantee complete recovery. A return to use should prompt support and reassessment, especially if physical or mental symptoms are worsening.
For more detail, see Understanding Ketamine Addiction and Ketamine Detox and Withdrawal.
